DSC Investment Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 12
- Investments
- 108
- Portfolio
- 68
- Exits
- 29
DSC Investment General Information
Description
DSC Investment is a venture capital firm that invests in companies operating in the bio and health, commerce, fintech, hardware and devices, and mobile and media sectors. The firm was founded in 2012 and is based in Seoul, South Korea.
Contact Information
Website
Year Founded
2012
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 10, Ttukseom-ro 1-gil
- 3rd floor
- Seoul, Seongdong-Gu
- South Korea
+82 00-0000-0000
DSC Investment Investments (108)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| CoImmune | 04-Nov-2020 | Later Stage VC | 0000 | Biotechnology | Generating Revenue | |
| 0000 | 01-Oct-2020 | 00000 00000 | 0000 | Entertainment Software | Generating Revenue | |
| 000000 (00000000 0 | 28-Sep-2020 | 00000 00000 | 000.00 | Internet Retail | Generating Revenue | |
| 0 00000000 | 01-Apr-2020 | 0000 00000 | 00.000 | Discovery Tools (Healthcare) | Generating Revenue | |
| 000 | 09-Mar-2020 | 00000 00000 | 00.000 | Information Services (B2C) | Generating Revenue | |
| 0000000 00 | 06-Mar-2020 | 00000 00000 | 000.00 | Automotive | Generating Revenue | |
| 0000 00000000 | 22-Jan-2020 | 00000 00000 | 0000 | Electronic Equipment and Instruments | Generating Revenue | |
| 0000000 0000000000 | 01-Jan-2020 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| Furiosa | 07-Nov-2019 | Early Stage VC | 00.00 | Application Specific Semiconductors | Generating Revenue | |
| Adicet Bio | 19-Sep-2019 | Early Stage VC | 0000 | Drug Discovery | Pre-Clinical Trials |
DSC Investment Exits (28)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Point Mobile | 01-Dec-2020 | IPO | 000.00 |
| 00000 000000 | 21-Aug-2020 | 000 00 00000000 | |
| 000 00000000000 | 17-Jun-2020 | 000 | 000.00 |
| 0000 000 | 22-Nov-2019 | 000 | |
| 0000000000 | 29-Oct-2019 | 000 | 00.00 |
| 000 00000000 | 22-Jul-2019 | 000 00 00000000 | |
| 000000 | 17-Jul-2019 | 000 | 0000 |
| 000000 | 20-Feb-2019 | 000 | |
| Genome & Company | 26-Dec-2018 | IPO | |
| ABL Bio | 22-Dec-2018 | IPO | 000.00 |
DSC Investment Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialDSC Investment Team (15)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Geon-soo Yoon | Chief Executive Officer | Seoul, South Korea | |||
| Tae-hoon Ha | General Partner | Seoul, South Korea | |||
| Min-ji Kim | Director | Seoul, South Korea | |||
| Jung-woon Park | Management Director | Seoul, South Korea | |||
| Kyung-ho Lee | Chief Team Leader | Seoul, South Korea |
DSC Investment Co-Investors (126)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Korea Investment Partners | 10 | 0 |
|
|
|
| IMM Investment | 0 |
|
|
||
| KB Investment | 0 | 0 |
|
|
|
| Kakao Ventures | 0 | 0 |
|
|
|
| Korea Development Bank | 0 |
|
|